Actos Bladder Cancer Lawsuits Consolidated in California
Jan 11, 2012 | 
Filed in: 
January 11, 2012 – All legal claims filed in California state court involving former Actos users who subsequently developed bladder cancer are now set to be consolidated and coordinated during pretrial proceedings. The California Judicial Counsel named Los Angeles Superior Court Judge Carl J…. Read More »
Topamax Oral Cleft Defect Risk May Hinder Approval of New Diet Drug
January 4, 2012 – Concerns about the risk of cleft lip and cleft palate birth defects from the maternal use of Topamax (generic: topiramate) during pregnancy may affect the approval status of a newly proposed weight loss medication that combines the anti-epileptic drug with… Read More »
FDA Calls for New Restrictions on Multaq Use
December 21, 2011 – This week, the U.S. Food & Drug Administration (FDA) issued a safety warning for Sanofi’s popular heart drug Multaq (dronedarone), indicating that it may double the risk of death, stroke and heart problems in patients with permanent atrial fibrillation. The… Read More »
Health Canada: Bisphosphonates Double Risk for Atypical Bone Fractures
December 20, 2011 – Canadian health regulators have issued a press release warning the public and medical communities that the side effects of a popular class of osteoporosis drugs may increase the risk of rare thigh bone fractures. In its warning, Health Canada stated… Read More »
Federal Panel Rejects Plavix MDL Consolidation
December 19, 2011 – Last week, a panel of judges denied a motion filed by Bristol-Myers Squibb and Sanofi-Aventis to consolidate all federal Plavix lawsuits for coordinated handling during pre-trial litigation. Individual Plavix injury cases will therefore proceed in various district courts throughout the… Read More »
PPI Bone Fracture Lawsuit Filed in California
December 14, 2011 – Earlier this month, an Arizona woman filed a legal claim against the manufacturers of a number of best-selling proton pump inhibitor (PPI) heartburn drugs including Nexium, Prilosec, Protonix, and Prevacid, claiming that the use of these medications caused her to… Read More »
Chantix Litigation Moving Forward
December 14, 2011 – A conference regarding the status of the federal Chantix litigation that was originally set to take place this Friday has been pushed back to January 20 after legal teams told the Court that discovery proceedings were going smoothly, and that… Read More »
FDA Denies Public Citizen’s Plea to Recall Avandia
November 30, 2011 – The U.S. Food & Drug Administration (FDA) has rejected a petition filed by consumer watchdog group Public Citizen to have the controversial diabetes drug Avandia recalled from the market. Public Citizen lashed out in response, suggesting that allowing Avandia to… Read More »
Accutane IBD Lawsuit Filed by New Jersey Woman
November 22, 2011 – Yet another Accutane trial has kicked off in New Jersey state court involving a young woman who allegedly contracted inflammatory bowel disease (IBD) after taking the now-banned prescription acne medication. The claim was filed on behalf of Priya Tanna, who… Read More »
Darvon & Darvocet MDL Claims Continue to Grow Nationwide
November 25, 2011 – To date, more than 100 Darvon and Darvocet complaints have been filed nationwide by plaintiffs in federal courts claiming that the now-banned prescription medications caused them serious heart-related side effects. As the lawsuits pile up, many familiar with these issues… Read More »
